We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Synthetic Membrane Channels Constructed with DNA-Based Nanostructures

By LabMedica International staff writers
Posted on 28 Nov 2012
Scientists have shown for the first time that synthetic, lipid-membrane channels can be constructed by using a technique employing DNA molecules as building materials for custom-designed, self-assembling, nanometer-scale structures. More...
The results suggest potential applications as molecular sensors, antimicrobial agents, and drivers of novel nanodevices.

Physicists at the Technical University of Munich (TUM; Garching, Germany) and the University of Michigan (Ann Arbor, MI, USA) have applied the emerging field of DNA-nanotechnology, including “scaffolded DNA origami,” to mimic the shape and function of one of the most widespread and important natural nanomachines – the biological transmembrane channel. The synthetic structure consists of a needle-like stem (42 nm long, 2 nm internal diameter) that penetrates and spans a lipid bilayer membrane. The stem is partly sheathed by a barrel-shaped cap that adheres to the membrane, in part via a ring of 26 cholesterol moieties around the edge of the cap that helps the device dock while the stem forms a channel. The device is formed by 54 double-helical DNA domains on a honeycomb lattice. Evidence is presented suggesting that these nanostructures function much like cellular ion channels. For example, in single-channel electrophysiological measurements there were similarities to natural ion channels, such as conductance on the order of 1 nanosiemens and channel gating.

"We have not tested this yet with living cells, but experiments with lipid vesicles show that our synthetic device will bind to a bilayer lipid membrane in the right orientation, [...] forming a pore," explains Prof. Friedrich Simmel, co-coordinator of the Excellence Cluster Nanosystems Initiative Munich. Further experiments demonstrated that the resulting pores have electrical conductivity that suggests they could act like the voltage-controlled gates present in cells and that the transmembrane current could be tuned by adjusting fine structural details.

This study of the first artificial channel suggests a number of potential applications. "If you want, for example, to inject something into a cell, you have to find a way to punch a hole into the cell membrane, and this device can do that, at least with model cell membranes," says Prof. Hendrik Dietz, a fellow of the TUM Institute for Advanced Study. To test one potential application, the researchers used these devices as "nanopores" for several different molecular sensing experiments and confirmed that it is possible, by measuring changes in electrical characteristics, to record the passage of single molecules. Because this approach allows both geometric and chemical tailoring of the membrane channels, it might offer advantages over two other families of molecular sensors, based on biological and solid-state nanopores respectively.

Other conceivable applications remain to be investigated. One notion is to imitate viruses or phages to kill targeted bacteria. Synthetic channels might be used as nanoneedles to inject material into cells for medical use such as gene-therapy or for basic studies of cell metabolism. Another idea is to harness the ion flux to drive sophisticated nanodevices.

The study was reported November 16, 2012, in the journal Science.

Related Links:
Technische Universitaet Muenchen
University of Michigan


Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
Online QC Software
Acusera 24•7
Japanese Encephalitis Test
Japanese Encephalitis Virus Real Time PCR Kit
All-in-One Molecular System
AIO M160
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Characterization of EV separated by distinct methods (Photo courtesy of Yuanyuan Liu, Yanbin Guo et al. Engineering, doi.org/10.1016/j.eng.2025.12.009)

Liquid Biopsy Biomarkers May Improve Childhood Epilepsy Diagnosis

Childhood epilepsy remains a major neurological disorder with unmet needs for accurate, non-invasive biomarkers, as conventional tests such as electroencephalography and neuroimaging can have limited sensitivity... Read more

Molecular Diagnostics

view channel
Image: NeoCircle Study Synopsis (George, A.M., Chen, Y., Gladchuk, S. et al. EMBO Molecular Medicine (2026). DOI: 10.1038/s44321-026-00447-z)

Ultrasensitive MRD Blood Test Detects Early Breast Cancer Recurrence

SAGA Diagnostics (Morrisville, NC, USA), a company specializing in tumor-informed, blood-based cancer detection and precision medicine, announced the publication of a new study evaluating its Pathlight... Read more

Pathology

view channel
Image: Immune-related signals in routine bone marrow biopsy slides could help predict multiple myeloma outcomes and support more personalized treatment strategies (image credit: Shutterstock)

AI Tool Extracts Immune Signals from Biopsy to Inform Myeloma Therapy

Multiple myeloma is a bone marrow malignancy in which patients can respond very differently to the same treatments, making initial therapy decisions difficult. Clinicians must choose among options such... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.